Cancer

October 4, 2012

An orphan enzyme’s purpose

“Orphan” enzyme may play role in cancer growth, new research suggests.

By VUMC News and Communications

September 27, 2012

Photo: Lung Cancer Partnership

By VUMC News and Communications

September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

By VUMC News and Communications

Vanderbilt LifeFlight's Marsha Roberts, Randy Hughes, Leah Smith, Kevin Mobley and Bric Baker show the pink flight name badges and shirts that LifeFlight staff will wear during the month of October. (Vanderbilt University)

September 26, 2012

LifeFlight goes pink for breast cancer awareness

By VUMC News and Communications

September 21, 2012

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

By VUMC News and Communications

September 20, 2012

Grant renewal boosts GI cancer research program

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI).

By VUMC News and Communications

September 13, 2012

Cells with LIP eat their neighbors

A transcription factor called LIP is capable of causing one cell to consume another.

By Leigh MacMillan

August 30, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care

Racial differences exist in quality surgical care, new research from VICC finds.

By VUMC News and Communications

August 23, 2012

Gene linked to familial prostate cancer

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

By VUMC News and Communications

August 16, 2012

African ancestry, stomach bug link

Socioeconomic factors, African ancestry linked to risk for cancer-causing infection.

By VUMC News and Communications

August 9, 2012

Study tracks how gene may promote lung cancer tumors

Vanderbilt-Ingram Cancer Center researchers have identified how one of the genes most commonly mutated in lung cancer may promote such tumors.

By VUMC News and Communications

August 2, 2012

Arteaga named to Komen scientific advisory board

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation.

By VUMC News and Communications

August 2, 2012

VICC’s Hassanein lands lung cancer research grant

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer.